Delivery Order SPE2DB20D3303-SPE2DB24FA0EP

Award Date 6/21/24
Potential Completion Date 6/24/24
Potential Value $10K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,679.26 firm fixed-price delivery order is for the supply of 4,565,672,909 units of abiraterone acetate 250 mg tablets. The award has a completion date of September 5, 2024 and was made on September 4, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $1,481.38, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of 4,566,734,838 units of Abiraterone Acetate 500 mg tablets. This is a Firm Fixed Price delivery order with a completion date of December 17, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,182.10 firm fixed-price delivery order contract is for the supply of 4,565,950,374 units of abiraterone acetate 250 mg tablets. The contract has an ultimate completion date of September 27, 2024. This delivery order is issued under AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,675.50 Firm Fixed Price contract is for the delivery of 4,555,550,333 units of Abiraterone Acetate 250 mg Tablets. This delivery order contract has a completion date of December 1, 2021. The contract award is a part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,804.99 firm-fixed-price delivery order is for 4,567,025,743 units of Abiraterone Acetate 500 mg tablets. The contract has an ultimate completion date of January 24, 2025. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $52,757.21 fixed-price delivery order is for the supply of 4,566,831,952 units of the pharmaceutical product abiraterone acetate 250 mg tablets. The contract has an ultimate completion date of January 6, 2025 and was awarded on January 3, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,851.38 firm-fixed-price delivery order is for the supply of 4,565,481,171 tablets of Abiraterone Acetate 250 mg, a medication used for the treatment of prostate cancer. The contract has an ultimate completion date of August 19, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,822.78 firm fixed price delivery order is for the supply of 4565133468 Abiraterone Acetate 250 mg tablets. The contract has a ceiling value of $1,822.78 and a completion date of July 15, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Abiraterone Acetate 500 mg tablets. The $13,720.67 firm fixed-price contract has a completion date of February 14, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,016.18, is a delivery order for the supply of Abiraterone Acetate 500 mg tablets. It is a firm fixed-price contract with a performance period ending on May 14, 2025. The contract is not designated as a set-aside and was awarded through open competition. AmerisourceBergen Drug Corp is the prime...
  • SPE2DB20D3303
    Indefinite Delivery Contract
  • SPE2DB20D3303-SPE2DB24FA0EP
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,491.64 firm fixed-price delivery order is for the supply of 4,564,965,578 units of Abiraterone Acetate 500 mg tablets, with a completion date of June 24, 2024.

The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support U.S. military healthcare programs globally. The contract encompasses critical medical commodities across multiple therapeutic areas. This contract award did not have a set-aside designation, indicating open competition.

Generated 5/17/25, 9:44 AM